|
Sokolova A.V., Dragunov D.O., Arutyunov G.P.
Screening for sarcopenia in patients with chronic heart failure and chronic kidney disease
|
№1 / 2024
|
|
Krysanov I.S., Makarova E.V., Ermakova V.Yu., Kurkin D.V.
Comparative pharmacoeconomic analysis of the use of epoetin alfa and roxadustat in combination with iron supplements in adult patients with anemia against the background of chronic kidney disease in the healthcare system of the Russian Federation
|
№1 / 2024
|
|
Popov S.V., Guseinov R.G., Yesayan A.M., Sivak K.V., Perepelitsa V.V., Sadovnikova A.V., Grushevsky R.O., Lelyavina T.A.
Analysis of functional results of surgical treatment of kidney cancer
|
№4 / 2023
|
|
Matveev M.D., Mikhailova Z.D.
Posttransfusion hemochromatosis and cardiorenal syndrome. Local register data
|
№4 / 2023
|
|
Pyatchenkov M.O., Sherbakov E.V., Trandidna A.E., Belskykh A.N.
Intestinal fatty acid binding protein as biomarker of enterocyte injury in patients with renal failure
|
№3 / 2023
|
|
Litvinov A.S., Gasanov M.Z., Kuznetsova Yu.V., Gergia S.R., Shevchenko S.V.
Mechanisms of albumin loss against the background of the use of modern methods of renal replacement therapy
|
№2 / 2023
|
|
Vorotylov A.A., Mikhailova Z.D.
Features of kidney damage in metabolic syndrome
|
№2 / 2023
|
|
Mikhailova N.A.
Methods of nutrition therapy of patients with chronic kidney disease
|
№1 / 2023
|
|
Zeinebekova A.B., Umarova A.M., Usmanova D.U., Turkara A.M., Kovalchuk V.E., Dyussenova S.B.
Early predictors of kidney damage in children and adolescents with type 1 diabetes mellitus
|
№1 / 2023
|
|
Frolova N.F., Tomilina N.A., Usatyuk S.S., Dyakova E.N., Sysoeva I.L., Terentyeva N.V., Frolov M.A., Kim I.G.
Interleukin-6 receptor inhibitor levilimab in the treatment of COVID-19 in patients with chronic kidney disease
|
№1 / 2023
|
|
Bachmakov I.E., Fedoseev A.N., Denisova V.E.
Insulin resistance in chronic kidney disease
|
№4 / 2022
|
|
Trushkin R.N., Medvedev P.E., Isaev T.K., Klementieva T.M., Morozov N.V., Ivanov K.V.
Modern strategies for the treatment of patients with autosomal dominant polycystic kidney disease
|
№4 / 2022
|
Русский
